Cannabinoid receptor-2 and HIV-associated neurocognitive disorders. (Q42206762)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25015040 AND SRC:MED&resulttype=core&format=json

9 March 2020

title

Cannabinoid receptor-2 and HIV-associated neurocognitive disorders (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25015040 AND SRC:MED&resulttype=core&format=json

9 March 2020

0 references

0 references

0 references

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25015040 AND SRC:MED&resulttype=core&format=json

9 March 2020

author name string

Vishnudutt Purohit

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25015040 AND SRC:MED&resulttype=core&format=json

9 March 2020

Rao S Rapaka

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25015040 AND SRC:MED&resulttype=core&format=json

9 March 2020

language of work or name

1 reference

1 September 2014

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25015040 AND SRC:MED&resulttype=core&format=json

Journal of Neuroimmune Pharmacology

9 March 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25015040 AND SRC:MED&resulttype=core&format=json

9 March 2020

volume

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25015040 AND SRC:MED&resulttype=core&format=json

9 March 2020

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25015040 AND SRC:MED&resulttype=core&format=json

9 March 2020

page(s)

447-453

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25015040 AND SRC:MED&resulttype=core&format=json

Short-term effects of cannabinoids in patients with HIV-1 infection: a randomized, placebo-controlled clinical trial

9 March 2020

cites work

1 reference

https://api.crossref.org/works/10.1007/S11481-014-9554-0

Identification of a novel domain of HIV tat involved in monocyte chemotaxis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11481-014-9554-0

Neuropsychological deficits in chronic cocaine abusers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11481-014-9554-0

Inflammatory changes and breakdown of microvascular integrity in early human immunodeficiency virus dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11481-014-9554-0

Neuropsychological performance of recently abstinent alcoholics and cocaine abusers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11481-014-9554-0

Changes in the incidence and predictors of human immunodeficiency virus-associated dementia in the era of highly active antiretroviral therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11481-014-9554-0

HIV-associated neurocognitive disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11481-014-9554-0

Early viral brain invasion in iatrogenic human immunodeficiency virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11481-014-9554-0

Tat protein is an HIV-1-encoded beta-chemokine homolog that promotes migration and up-regulates CCR3 expression on human Fc epsilon RI cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11481-014-9554-0

Immune activation of the central nervous system is still present after >4 years of effective highly active antiretroviral therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11481-014-9554-0

HIV-1 Tat and opiate-induced changes in astrocytes promote chemotaxis of microglia through the expression of MCP-1 and alternative chemokines

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11481-014-9554-0

Cannabinoids ablate release of TNFalpha in rat microglial cells stimulated with lypopolysaccharide

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11481-014-9554-0

Synaptic dysfunction in the hippocampus accompanies learning and memory deficits in human immunodeficiency virus type-1 Tat transgenic mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11481-014-9554-0

Cannabinoids Inhibit Migration of Microglial-like Cells to the HIV Protein Tat

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11481-014-9554-0

Current understanding of HIV-associated neurocognitive disorders pathogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11481-014-9554-0

The neuropathogenesis of AIDS

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11481-014-9554-0

Immunoregulation of a CB2 receptor agonist in a murine model of neuroAIDS

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11481-014-9554-0

Neurocognitive disturbances in HIV.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11481-014-9554-0

HIV-associated neurocognitive disorders persist in the era of potent antiretroviral therapy: CHARTER Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11481-014-9554-0

Induction of C chemokine XCL1 (lymphotactin/single C motif-1 alpha/activation-induced, T cell-derived and chemokine-related cytokine) expression by HIV-1 Tat protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11481-014-9554-0

Human immunodeficiency virus protein Tat induces synapse loss via a reversible process that is distinct from cell death

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11481-014-9554-0

Cannabinoids inhibit network-driven synapse loss between hippocampal neurons in culture

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11481-014-9554-0

Activation of Cannabinoid Type 2 Receptors Inhibits HIV-1 Envelope Glycoprotein gp120-Induced Synapse Loss

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11481-014-9554-0

A coat of many colors: neuroimmune crosstalk in human immunodeficiency virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11481-014-9554-0

HIV-1 neuroimmunity in the era of antiretroviral therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11481-014-9554-0

Entangled epidemics: cocaine use and HIV disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11481-014-9554-0

The effect of recent stimulant use on sustained attention in HIV-infected adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11481-014-9554-0

Cannabinoids inhibit HIV-1 Gp120-mediated insults in brain microvascular endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11481-014-9554-0

ART suppresses plasma HIV-1 RNA to a stable set point predicted by pretherapy viremia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11481-014-9554-0

Neurocognitive impairment and medication adherence in HIV patients with and without cocaine dependence

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11481-014-9554-0

A cannabinoid agonist interferes with the progression of a chronic model of multiple sclerosis by downregulating adhesion molecules.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11481-014-9554-0

CB2 receptor-mediated migration of immune cells: it can go either way

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11481-014-9554-0

Multiple actions of the human immunodeficiency virus type-1 Tat protein on microglial cell functions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11481-014-9554-0

Cannabinoid Administration Attenuates the Progression of Simian Immunodeficiency Virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11481-014-9554-0

Low-level viremia persists for at least 7 years in patients on suppressive antiretroviral therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11481-014-9554-0

Blood-brain barrier: structural components and function under physiologic and pathologic conditions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11481-014-9554-0

Cannabinoids and morphine differentially affect HIV-1 expression in CD4( ) lymphocyte and microglial cell cultures

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11481-014-9554-0

The role of cannabinoids in inflammatory modulation of allergic respiratory disorders, inflammatory pain and ischemic stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11481-014-9554-0

HIV-1 tat protein upregulates inflammatory mediators and induces monocyte invasion into the brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11481-014-9554-0

Cannabinoid inhibition of macrophage migration to the trans-activating (Tat) protein of HIV-1 is linked to the CB(2) cannabinoid receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11481-014-9554-0

CB2-receptor stimulation attenuates TNF-alpha-induced human endothelial cell activation, transendothelial migration of monocytes, and monocyte-endothelial adhesion

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11481-014-9554-0

Activation of cannabinoid receptor 2 attenuates leukocyte-endothelial cell interactions and blood-brain barrier dysfunction under inflammatory conditions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11481-014-9554-0

Attenuation of HIV-1 replication in macrophages by cannabinoid receptor 2 agonists

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11481-014-9554-0

Personality profile and neuropsychological test performance in chronic cocaine-abusers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11481-014-9554-0

Developments in HIV neuropathogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11481-014-9554-0

Dendritic changes in the hippocampal formation of AIDS patients: a quantitative Golgi study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11481-014-9554-0

Editorial NeuroAIDS review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11481-014-9554-0

Central nervous system immune activation characterizes primary human immunodeficiency virus 1 infection even in participants with minimal cerebrospinal fluid viral burden

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11481-014-9554-0

Potential roles of microglial cell progranulin in HIV-associated CNS pathologies and neurocognitive impairment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11481-014-9554-0

HIV-associated neurological disorders: a guide to pharmacotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11481-014-9554-0

Central nervous system damage produced by expression of the HIV-1 coat protein gp120 in transgenic mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11481-014-9554-0

Profile of executive deficits in cocaine and heroin polysubstance users: common and differential effects on separate executive components.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11481-014-9554-0

Brain cannabinoid CB₂ receptors modulate cocaine's actions in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11481-014-9554-0

Anti-inflammatory property of the cannabinoid receptor-2-selective agonist JWH-133 in a rodent model of autoimmune uveoretinitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11481-014-9554-0

Interleukin-1β Released by gp120 Drives Neural Death through Tyrosine Phosphorylation and Trafficking of NMDA Receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11481-014-9554-0

Activation of monocytes by HIV-Tat treatment is mediated by cytokine expression

21 January 2018

1 reference

12 December 2020

Cannabinoid receptor 2-mediated attenuation of CXCR4-tropic HIV infection in primary CD4 T cells

1 reference

12 December 2020

Synthetic nonpsychotropic cannabinoids with potent antiinflammatory, analgesic, and leukocyte antiadhesion activities

1 reference

12 December 2020

Human immunodeficiency virus-associated neurocognitive disorders: Mind the gap

1 reference

12 December 2020

Cannabinoids inhibit LPS-inducible cytokine mRNA expression in rat microglial cells

1 reference

12 December 2020

Cocaine enhances monocyte migration across the blood-brain barrier. Cocaine's connection to AIDS dementia and vasculitis?

1 reference

12 December 2020

Stimulation of cannabinoid receptor 2 (CB2) suppresses microglial activation

1 reference

12 December 2020

Decreased cocaine motor sensitization and self-administration in mice overexpressing cannabinoid CB₂ receptors.

1 reference

12 December 2020

Tat-human immunodeficiency virus-1 induces human monocyte chemotaxis by activation of vascular endothelial growth factor receptor-1

1 reference

12 December 2020

Update on HIV-associated neurocognitive disorders

1 reference

12 December 2020

A prospective study of HIV disease progression in female and male drug users

1 reference

12 December 2020

WIN55,212-2-mediated inhibition of HIV-1 expression in microglial cells: involvement of cannabinoid receptors

1 reference

12 December 2020

Early entry and widespread cellular involvement of HIV-1 DNA in brains of HIV-1 positive asymptomatic individuals

1 reference

12 December 2020

10.1007/S11481-014-9554-0

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25015040 AND SRC:MED&resulttype=core&format=json

9 March 2020

1 reference